Information for the public
Cabazitaxel (Jevtana), with prednisone or prednisolone, is recommended as a possible treatment for people with metastatic hormone-relapsed prostate cancer if:
it has been treated with docetaxel
they have an eastern cooperative oncology group performance status of 0 or 1.
Cabazitaxel should be stopped if the disease gets worse or after 10 cycles of treatment (whichever happens first).